Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinsons Disease (PD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06944522
What this trial is testing

Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

Who this might be right for
Parkinsons Disease (PD)
BlueRock Therapeutics 102
Not applicableStudy completedNCT07240272
What this trial is testing

TACS Modulates Speech and Cognitive Impairments in People With PD by Targeting the Medial Frontal Cortex

Who this might be right for
Parkinson Disease
Ke Dong, MD 28
Early research (Phase 1)Looking for participantsNCT04396873
What this trial is testing

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

Who this might be right for
Parkinson's DiseaseDementiaAlzheimer's Disease+2 more
National Institute of Mental Health (NIMH) 184
Post-approval studies (Phase 4)Study completedNCT06263673
What this trial is testing

Anti-Diabetic Medications to Fight PD and LBD

Who this might be right for
Lewy Body DementiaParkinson Disease
Mayo Clinic 18
Not applicableStudy completedNCT07430722
What this trial is testing

Cross-sectional Study of Vitamin B6 in Parkinson's Disease

Who this might be right for
Parkinson's Disease (PD)
University of Rochester 288
Testing effectiveness (Phase 2)Study completedNCT03840005
What this trial is testing

Trial of Ursodeoxycholic Acid (UDCA) for Parkinson's Disease: The "UP" Study

Who this might be right for
Parkinson's Disease
Sheffield Teaching Hospitals NHS Foundation Trust 31
Very early researchNot Yet RecruitingNCT07085195
What this trial is testing

A Clinical Study of the Safety and Efficacy of Chemogenetics Therapy in the Treatment of Parkinson's Disease

Who this might be right for
Parkinson Disease (PD)Gene TherapySafety and Efficacy+1 more
Ruijin Hospital 6
Not applicableNot Yet RecruitingNCT06984393
What this trial is testing

Tele-Rehabilitation Intervention in Community-Based Healthcare for Patients With Parkinson's Disease (DHEAL-COM-PD)

Who this might be right for
Parkinson DiseaseOlder People
Istituto Nazionale di Ricovero e Cura per Anziani 40
Large-scale testing (Phase 3)Study completedNCT00275275
What this trial is testing

Pramipexole Conversion to Ropinirole Controlled Release (CR)

Who this might be right for
Parkinson Disease
Rajesh Pahwa, MD 61
Testing effectiveness (Phase 2)Study completedNCT00753519
What this trial is testing

Transcranial Magnetic Stimulation to Treat Parkinson's Disease

Who this might be right for
Parkinson Disease
Mark Hallett 28
Early research (Phase 1)Study completedNCT02169895
What this trial is testing

Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Immediate-release Levodopa/Benserazide

Who this might be right for
Parkinson's Disease (PD)
Bial - Portela C S.A. 16
Not applicableStudy completedNCT02202057
What this trial is testing

Respiratory Load Magnitude Estimation in PD

Who this might be right for
Parkinson's DiseaseAging
University of Florida 30
Post-approval studies (Phase 4)Looking for participantsNCT06013956
What this trial is testing

Personalized Real-Time DBS and PD Mechanisms

Who this might be right for
Parkinson Disease
David Escobar 25
Post-approval studies (Phase 4)Study completedNCT00144300
What this trial is testing

Ophthalmologic Safety Study of Pramipexole Immediate Release (IR) Versus Ropinirole in Early Parkinson's Disease (PD) Patients

Who this might be right for
Parkinson Disease
Boehringer Ingelheim 246